Multicenter target trial emulation to evaluate corticosteroids for sepsis stratified by predicted organ dysfunction trajectory
- PMID: 40360520
- PMCID: PMC12075795
- DOI: 10.1038/s41467-025-59643-z
Multicenter target trial emulation to evaluate corticosteroids for sepsis stratified by predicted organ dysfunction trajectory
Abstract
Corticosteroids decrease the duration of organ dysfunction in sepsis and a range of overlapping and complementary infectious critical illnesses, including septic shock, pneumonia and the acute respiratory distress syndrome (ARDS). The risk and benefit of corticosteroids are not fully defined using the construct of organ dysfunction duration. This retrospective multicenter, proof-of-concept study aimed to evaluate the association between usage of corticosteroids and mortality of patients with sepsis, pneumonia and ARDS by emulating a target trial framework stratified by predicted organ dysfunction trajectory. The study employed a two staged machine learning (ML) methodology to first subphenotype based on organ dysfunction trajectory then predict this defined trajectory. Once patients were classified by predicted trajectory we conducted a target trial emulation. Our analysis revealed that the association between corticosteroid use and 28-day mortality varied by predicted trajectory and between cohorts.Our findings suggest that matching treatment strategies to empirically observed pathobiology may offer a more nuanced understanding of corticosteroid utility.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: E.S. received personal fees from Axle Informatics outside of stated work. The remaining authors declare no competing interests.
Figures
Update of
-
Corticosteroids for infectious critical illness: A multicenter target trial emulation stratified by predicted organ dysfunction trajectory.medRxiv [Preprint]. 2024 Mar 8:2024.03.07.24303926. doi: 10.1101/2024.03.07.24303926. medRxiv. 2024. Update in: Nat Commun. 2025 May 13;16(1):4450. doi: 10.1038/s41467-025-59643-z. PMID: 38496630 Free PMC article. Updated. Preprint.
References
-
- Maslove, D. M. et al. Redefining critical illness. Nat. Med.28, 1141–1148 (2022). - PubMed
-
- Martin-Loeches, I., Diaz, E. & Valles, J. Risks for multidrug-resistant pathogens in the ICU. Curr. Opin. Crit. Care25, 433–441 (2019). - PubMed
-
- Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet392, 75–87 (2018). - PubMed
-
- Heming, N. et al. APROCCHSS investigators and CRICS-TRIGGERSEP network. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respir. Med.12, 366–374 (2024). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
